SBIR-STTR Award

Nutritional Therapy in Elderly with Heart Failure
Award last edited on: 4/1/2019

Sponsored Program
STTR
Awarding Agency
NIH : NIA
Total Award Amount
$1,219,498
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Robert R Wolfe

Company Information

Essential Blends LLC

1930 Lynx Lane
Fairbanks, AK 99709
   (281) 910-1648
   N/A
   essentialblends.co/

Research Institution

University of Arkansas

Phase I

Contract Number: 1R41AG050375-01
Start Date: 8/15/2015    Completed: 7/31/2016
Phase I year
2015
Phase I Amount
$149,721
?The long-term goal of this project is to develop and test a nutritional product that will improve physical function in individuals with heart failure (H) in the geriatric population. Our approach to nutritional therapy (NT) focuses on increasing skeletal muscle strength, improving vascular reactivity and optimizing regulation of energy substrate metabolism. All of these anticipated responses to NT should contribute to improved physical performance and thereby interrupt the vicious cycle of heart failure progression that ultimately leads to morbidity and mortality. While the popularity of nutritional supplements designed to address specific health concerns has grown, the credibility of the field has suffered due to an abundance of unsubstantiated claims and unscrupulous sales approaches. Essential Blends LLC is committed to marketing only products that have been developed from sound theory and validated by tightly controlled clinical trials. Thus, our ultimate goal is to perform a tightly controlled clinical trial assessing the response of individuals with HF to NT using our proprietary blend of amino acids. In order to perform such a study, a number of issues must be resolved. It is therefore the goal of this Phase I project to make all the necessary preparations t efficiently perform a controlled clinical trial in the subsequent Phase II aspect of this project. Following are the Specific Aims of this Phase I proposal: Specific Aim 1. To develop a palatable beverage that incorporates all of the essential components in the appropriate amounts in a format that can be produced relatively inexpensively. Specific Aim 2. To perform a pilot study to determine variability in determination of functional capacity in individuals with HF in order to determine the necessary number of subjects for the clinical trial, and to predict power reasonably accurately. Specific Aim 3. To prepare existing data management capabilities for the clinical trial and to expand the subject registry. The outcome of this Phase I project will be completion of all aspects of preparation to perform a clinical trial assessing the benefits of NT with our nutritional formulation.

Public Health Relevance Statement:


Public Health Relevance:
This project will develop a nutritional beverage to improve physical function in elderly individuals with heart failure. The Phase I project will formulate the beverage and perform the necessary experiments and actions to fully prepare for a randomized clinical trial for the Phase II aspect of this project.

NIH Spending Category:
Aging; Cardiovascular; Clinical Research; Clinical Trials and Supportive Activities; Heart Disease; Nutrition; Prevention

Project Terms:
Activities of Daily Living; Address; Amino Acids; Arginine; base; Behavior; Beverages; Blood Vessels; Carbohydrates; Carbon Dioxide; Cardiac; Clinical Trials; Controlled Clinical Trials; data management; design; Development; Dietary Supplements; Drug Formulations; Elderly; Energy Metabolism; Essential Amino Acids; Exercise; Goals; Health; Heart failure; Impairment; improved; Individual; Insulin; Insulin Resistance; insulin sensitivity; Marketing; Metabolic; Metabolism; Morbidity - disease rate; Mortality Vital Statistics; Muscle Cells; Muscle Fatigue; muscle form; Muscle function; Muscle Proteins; muscle strength; Muscle Weakness; Nature; Nitric Oxide; Nutritional; Nutritional Support; Obesity; Outcome; Oxygen; Oxygen Consumption; Performance; Phase; Physical Function; Pilot Projects; Population; Preparation; Production; Protein Biosynthesis; protein degradation; Proteins; public health relevance; Randomized Clinical Trials; Registries; Regulation; research study; response; Sales; sarcopenia; sedentary; skeletal; Skeletal muscle structure; sound; Testing; theories; Tissues; Vascular blood supply; Vasodilation; Weight Gain

Phase II

Contract Number: 2R42AG050375-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2017
(last award dollars: 2018)
Phase II Amount
$1,069,777

We have developed a nutritional formulation of amino acids called UpBeat that is designed to promote physical function and quality of life in older individuals with heart failure. Reduced exercise capacity is a prominent clinical feature of heart failure. This leads to progressive muscle weakness and a vicious cycle of sedentary behavior, weight gain, and subsequent development of metabolic abnormalities and sarcopenia. The impairment of physical function limits the health-related quality of life. Because of the limited capacity for exercise in most individuals with heart failure and the failure of drug therapy to completely resolve the symptoms, a wide variety of nutritional products have been marketed for therapy for heart failure. The data supporting the value of nutritional supplements for heart failure currently on the market either do not exist or are equivocal. UpBeat differs from most nutritional products for heart failure because it targets skeletal muscle function, and its value is supported by strong preliminary data. It is the goal of the current proposal to perform a randomized clinical trial (RCT) to test the ability of UpBeat to improve physical function and quality of life in older individuals with heart failure. The Specific Aims of this Phase II project are as follows: Specific Aim #1: We propose that 16 weeks of regular consumption of UpBeat will improve physical function in individuals with heart failure. Specific Aim #2: We propose that regular consumption of UpBeat will improve health-related quality of life. Specific Aim #3: We propose that regular consumption of UpBeat will lower the fasting concentrations of blood glucose and insulin, as well as triglycerides and low-density lipids. Positive results of this randomized clinical trial will provide evidence of the benefits of UpBeat for therapy of heart failure. In a more general sense, positive results will substantiate the benefits of targeting skeletal muscle function as a means to improve physical function and quality of life in heart failure.

Public Health Relevance Statement:
8. Project Narrative Reduced exercise capacity is a prominent clinical feature of heart failure. This leads to progressive muscle weakness and a vicious cycle of sedentary behavior, weight gain, and subsequent development of metabolic abnormalities and sarcopenia. We have developed a nutritional formulation of amino acids called UpBeat that is designed to promote physical function and quality of life in older individuals with heart failure. In this project we will perform a randomized clinical trial of UpBeat as compared to a placebo in order to determine effects on physical function and health-related quality of life.

Project Terms:
Activities of Daily Living; Adverse effects; Amino Acids; Blood flow; Blood Glucose; Cardiac; Clinical; Comorbidity; Consumption; Data; density; design; Development; dietary supplements; Drug usage; Effectiveness; EFRAC; Elderly; Emotional; Exercise; exercise capacity; exercise training; Exertion; Failure; Fasting; Fatty Acids; Feeling; Formulation; Gait speed; Goals; Hand Strength; Health; health related quality of life; Heart failure; heart function; Impairment; improved; Individual; Insulin; Leg; Lipids; Measures; Metabolic; metabolic abnormality assessment; Methodology; Muscle function; Muscle Mitochondria; Muscle Proteins; Muscle Weakness; Nitric Oxide; Nutritional; Nutritional Support; Oxides; Patients; Pharmaceutical Preparations; Pharmacology; Pharmacotherapy; Phase; phase 1 study; phase I trial; physical conditioning; Physical Function; Placebos; Production; Protein Biosynthesis; Quality of life; Questionnaires; Randomized Clinical Trials; Resistance; response; sarcopenia; sedentary lifestyle; SF-36; Skeletal Muscle; social; stable isotope; Surveys; Symptoms; Testing; Tracer; Translating; Triglycerides; Walking; Weight Gain